About Reddy Pharmaceuticals Limited
Data last updated:
Reddy Pharmaceuticals Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG1996PLC116710. Its GSTIN is 36AAACR5329J1Z9 (Telangana). The company holds 8 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2.6 Cr and a paid-up capital of ₹2.6 Cr. It was formerly known as Reddy Pharmaceuticals Private Limited. It is led by directors including Konda Raghurami Reddy and Surya Kiran Reddy Konda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd Floor Ayyanna Corporate Plot No.350 Road No.8 Kakateeya Hills, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.05 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹98.19 Lakh (net margin -93.5%) and EBITDA of -₹52.54 Lakh (EBITDA margin -50%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 51% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Reddy Pharmaceuticals Limited. As per MCA filings, the company has open charges of ₹5 Lakh and satisfied charges of ₹4.35 Cr on record. Court records list 57 cases involving the company, including 27 filed by the company and 30 filed against it; 14 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reddypharma.com.
Company details
CIN history
Reddy Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232DL1996PLC075240. The current CIN is U24232TG1996PLC116710, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG1996PLC116710 | Current |
| U24232DL1996PLC075240 | Previous |
Contact details
Reddy Pharmaceuticals Limited's registered office is in Hyderabad, Telangana. Its website is reddypharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2nd Floor Ayyanna Corporate Plot No.350 Road No.8 Kakateeya Hills, Hyderabad, Telangana, India – 500081
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Reddy Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Reddy Pharmaceuticals operates one associated brand: Reddy Pharmaceuticals Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical supply of APIs, bulk drugs, and formulations in India. | reddypharma.com |
Business activity
The main business activity of Reddy Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reddy Pharmaceuticals Limited, buy the company report.
Financials of Reddy Pharmaceuticals Limited
FY 2025 filings availableReddy Pharmaceuticals Limited reported revenue of ₹1.05 Cr (down 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 51% over five years, including a 19% fall in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹52.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹98.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -50% | ||||
| Net Profit Margin | -93.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reddy Pharmaceuticals Limited, buy the company report.
Board of directors of Reddy Pharmaceuticals Limited
Reddy Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Konda Raghurami Reddy Also directs: Ethicaa Trading LLP, Reddy Seeds Private Limited, Reddy Agrofarms Private Limited and 5 more | Director | 05 Jan 1996 | 30 Years 9 Months | Current |
| Surya Kiran Reddy Konda Also directs: Kiom Pharmaceuticals (OPC) Private Limited | Director | 30 Sep 2023 | 3 Years 1 Months | Current |
| Vishnu Vardhan Reddy Konda Also directs: Reddy Limited, Reddy Biotec Limited | Director | 10 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Reddy Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Solvmed Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | 6.0% | Darbhanga, Bihar, India | |||
| Nushen Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | 23.0% | Mumbai, Maharashtra, India | |||
| Reddy Pharmaceuticals Limitedthis company | ₹1.05 Cr (FY 2024) | -₹98.19 Lakh | -93.5% | -19.0% | 1 | Hyderabad, Telangana, India |
| One Pharma Drugs & Pharmaceuticals Private Limited | ₹1.04 Cr (FY 2024) | 8.0% | New Delhi, Delhi, India | |||
| Biomarilyn Pharmaceuticals Private Limited | ₹1.04 Cr (FY 2024) | 14.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Reddy Pharmaceuticals Limited, buy the company report.
Auditor
Reddy Pharmaceuticals Limited is audited by MSPR&CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSPR&CO | FY 2021 | 010152S |
Shareholding
The shareholding of Reddy Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Reddy Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Sep 1989 | 90052289 | P.N.B. | ₹5 Lakh | Open | |
| 24 Mar 2016 | 100029147 | Karnataka Bank Ltd. | ₹2.7 Cr | Satisfied | |
| 15 Oct 2004 | 90055483 | Syndicate Bank | ₹1.65 Cr | Satisfied |
To see the full charge records of Reddy Pharmaceuticals Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Reddy Pharmaceuticals Limited has 57 court cases on record: 27 filed by Reddy Pharmaceuticals, 30 filed against it. 14 cases are pending and 43 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 35 | 23 | 5 |
| High courts | 14 | 7 | 3 |
| Supreme Court | 8 | 0 | 6 |
Cases on record (5 of 57)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case | Filed by the company against M S Dr Reddys Laboratories Limited Managing Director | Pending |
| High Court of Delhi | Court case (EX.P.) | Filed against the company by Dr. Reddys Laboratories Limited | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against Pureca Laboratories Pvt. Ltd., Rep by Vaibhav Vohra and 1 other | Pending |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against M/S. Bochem Healthcare Pvt. Ltd., and 4 others | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Dr. Reddys Laboratories Ltd. and Anr | Pending |
To see the full case history of Reddy Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Reddy Pharmaceuticals Limited was last rated by Icra on 29 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 29 Nov 2021 |
To see the full credit ratings and regulatory alerts of Reddy Pharmaceuticals Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reddy Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Reddy Pharmaceuticals has 1 associated company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
Employees & EPFO
Reddy Pharmaceuticals Limited has a workforce of 1 employees on its EPFO records as of Apr 02, 2024, across 2 active EPFO establishments.
GST
Reddy Pharmaceuticals has 8 GST registrations: 2 active and 6 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACR5329J1Z9 | Telangana | Active | 01 Jul 2017 |
| 07AAACR5329J1ZA | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reddy Pharmaceuticals Limited, buy the company report.
Recent activity
Reddy Pharmaceuticals Limited has 8 board changes on record since 1996: 3 appointments and 5 cessations. The latest: Sivakumar Reddy Aluru ceased to be Director on 30 Sep 2023.
6 earlier events are in the company report.
Frequently asked questions
Reddy Pharmaceuticals is an active public limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 1996 (30+ years old) and is registered under CIN U24232TG1996PLC116710.
Reddy Pharmaceuticals has 3 current directors:
- Konda Raghurami Reddy - Director
- Surya Kiran Reddy Konda - Director
- Vishnu Vardhan Reddy Konda - Director
The latest financial statements of Reddy Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reddy Pharmaceuticals is 36AAACR5329J1Z9, registered in Telangana. The company has 8 GST registrations in all, of which 2 are active and 6 are cancelled or inactive. Other active GSTINs include 07AAACR5329J1ZA (Delhi).
The CIN (Corporate Identification Number) of Reddy Pharmaceuticals is U24232TG1996PLC116710. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reddy Pharmaceuticals has 57 court cases on record: 27 filed by the company and 30 filed against it. 14 are pending. Most are in the district courts.
Reddy Pharmaceuticals was incorporated on 05 January 1996, making it 30+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Reddy Pharmaceuticals by revenue are Solvmed Pharmaceuticals Private Limited, Nushen Pharmaceuticals Private Limited, One Pharma Drugs & Pharmaceuticals Private Limited, Biomarilyn Pharmaceuticals Private Limited, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sivakumar Reddy Aluru ceased to be Director on 30 Sep 2023. Surya Kiran Reddy Konda was appointed as Director on 30 Sep 2023. Vishnu Vardhan Reddy Konda was appointed as Director on 10 Feb 2016. Reddy Pharmaceuticals has 8 board changes on record in total.
Reddy Pharmaceuticals can be reached through the website reddypharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Reddy Pharmaceuticals is at 2nd Floor Ayyanna Corporate Plot No.350 Road No.8 Kakateeya Hills, Hyderabad, Telangana, India – 500081.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
